Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CG✓SelectedUSD · CGMRNA vs CG performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs CG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-25.4%
CG return
-23.4%
Excess return
-2.0%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCGExcessAlpha
1D-4.8%+0.5%-5.4%-5.1%
7D-20.9%-5.8%-15.1%-18.2%
30D-13.3%+6.0%-19.2%-16.1%
3M+212.6%-19.9%+232.5%+254.5%
6M+309.0%-16.3%+325.3%+348.7%
YTD+567.3%-33.1%+600.4%+713.1%
1Y+689.7%-23.4%+713.1%+800.4%
3Y+157.4%+33.1%+124.4%+113.5%
All-25.4%-23.4%-2.0%-27.7%

Cumulative growth

Daily Returns

Daily percentage return beside CG.

Daily Out/Under-Performance

Portfolio return minus CG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling